Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Other Non Operating Income (2018 - 2025)

Bicycle Therapeutics' Other Non Operating Income history spans 4 years, with the latest figure at -$4000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income changed N/A year-over-year to -$4000.0; the TTM value through Dec 2025 reached $700000.0, up 184.54%, while the annual FY2025 figure was $700000.0, 173.38% up from the prior year.
  • Other Non Operating Income reached -$4000.0 in Q4 2025 per BCYC's latest filing, down from $158000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $745000.0 in Q2 2025 to a low of -$1.0 million in Q3 2024.